000538.SZ
云南白药
SZSE · Healthcare · C 制造业 · CN
CNY 49.50
+0.34%Margins
Gross margin
29.3%
EBITDA margin
15.1%
EBIT margin
14.6%
Net margin
12.5%
FCF margin
10.1%
12.5%
Return on equity
9.3%
Return on assets
14.5%
Return on invested capital
0.76x
Asset turnover
CNY 4.7B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026